UNSPSC 51285312: Nifurethazone

This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 699M5Q0YKN. European Medicines Agency schedules Nifurethazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09264MIG. Nifurethazone generally arises in the molecular formula C10H15N5O4.

UNSPSC 51285312 Nifurethazone is a Commodity code, but the code shows little relevant recent activity. The four most recent state and local opportunities tagged under this code—a naloxone and drug deactivation systems purchase from Seminole County, Florida; a pharmacy direct-to-manufacturer request for information from Texas HHS; a medical and first aid supplies solicitation from the City of Tampa Fire Department; and a generic multi-source pharmaceuticals and OTC products cooperative purchasing agreement from Minnesota—span naloxone, emergency medical supplies, prescription fulfillment infrastructure, and broad pharmaceutical product lines. None of these opportunities target nifurethazone, a specific pharmaceutical compound. The mismatch between the code's nominal scope and the actual work being solicited suggests either systematic misclassification in these state and local procurement notices or that nifurethazone itself sees minimal direct procurement activity at state and local level.

The issuing bodies span state health agencies, county public health departments, municipal fire and rescue divisions, and multistate cooperative purchasing organizations; however, none of the opportunities describe nifurethazone procurement specifically. Geographic spread includes Florida, Texas, Minnesota, and Oregon through cooperative purchasing. Absent a recent opportunity that actually targets nifurethazone, this code does not support a business development focus for firms selling that specific product into state and local markets.